Effect of high soy diet on the cerebrovasculature and endothelial nitric oxide synthase in the ovariectomized rat.
High soy (HS) diets are neuroprotective and promote vascular dilatation in the periphery. We hypothesized that an HS diet would promote vascular dilatation in the cerebrovasculature by mimicking estradiol's actions on the endothelial nitric oxide synthase (eNOS) system including increasing eNOS expression and decreasing caveolin-1 expression to increase nitric oxide (NO) production. Ovariectomized rats were fed HS or a soy-free diet (SF)+/-low physiological estradiol (E2) for 4weeks. Neither E2 nor HS altered middle cerebral artery (MCA) structure or vascular responses to acetylcholine, serotonin, or phenylephrine. Estradiol enhanced bradykinin-induced relaxation in an eNOS-dependent manner. Although E2 and HS increased eNOS mRNA expression in the brain and cerebrovasculature, they had no effect on eNOS protein expression or phosphorylation in the MCA. However, E2 decreased caveolin-1 protein in the MCA. In MCAs neither E2 nor HS altered estrogen receptor (ER) alpha expression, but E2 did reduce ER beta levels. These data suggest that HS diets have no effect on vascular NO production, and that E2 may modulate basal NO production by reducing the expression of caveolin-1, an allosteric inhibitor of NOS activity. However, the effects of E2 and HS on the cerebrovasculature are small and may not underlie their protective actions in pathological states.
Schreihofer
Derek A
DA
Department of Physiology, Medical College of Georgia, Augusta, GA 30912-3000, USA. dschreihofer@mcg.edu
Deutsch
Christian
C
Lovekamp-Swan
Tara
T
Sullivan
Jennifer C
JC
Dorrance
Anne M
AM
D000818:Animals; D051242:Caveolin 1 / Q000187:drug effects / Q000235:genetics; D004032:Diet; D004958:Estradiol / Q000494:pharmacology; D047629:Estrogen Receptor beta / Q000187:drug effects / Q000378:metabolism; D005260:Female; D015971:Gene Expression Regulation, Enzymologic / Q000187:drug effects; D007529:Isoflavones / Q000008:administration & dosage / Q000494:pharmacology*; D020768:Middle Cerebral Artery / Q000187:drug effects / Q000378:metabolism; D009569:Nitric Oxide / Q000378:metabolism; D052250:Nitric Oxide Synthase Type III / Q000187:drug effects* / Q000235:genetics / Q000378:metabolism; D010052:Ovariectomy; D012333:RNA, Messenger / Q000378:metabolism; D051381:Rats; D017207:Rats, Sprague-Dawley; D013025:Glycine max / Q000737:chemistry*; D014664:Vasodilation / Q000187:drug effects*
D051242:Caveolin 1; D047629:Estrogen Receptor beta; D007529:Isoflavones; D012333:RNA, Messenger; D009569:Nitric Oxide; D004958:Estradiol; D052250:Nitric Oxide Synthase Type III